Characterization of quinoxaline derivatives for protection against iatrogenically induced hearing loss is a research paper published in JCI Insight (2021). On theSindex it has a DataRank of 0.406. It has been cited 14 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.406
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: R01DC015444
National Institutes of Health
Grant: R01DC015010
U.S. Army Medical Research and Materiel Command
Grant: RH170030
Office of Naval Reactors
Grant: N00014-18-1-2507
Creighton University
Grant: LB692
Bellucci Foundation
Grant: Bellucci Foundation
Department of Defense United States
Grant: RH190050
National Institutes of Health
Grant: 7R01DC015444-03
Discovery of In Vivo Small Molecules for Hearing Protection Against Cisplatin and Noise
National Institutes of Health
Grant: 5R01DC015010-04
Genetic control of cellular conversion in the mature cochlea
FWCI
1.08
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals